TVGN (Tevogen Bio Holdings) 1-Year Share Buyback Ratio : -7.60% (As of Dec. 2024 )

View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings 1-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

1-Year Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past year, calculated as the percentage change in shares outstanding from the previous year to the current year. A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance. Tevogen Bio Holdings's current 1-Year Share Buyback Ratio was -7.60%.

TVGN's 1-Year Share Buyback Ratio is ranked better than
62.35% of 1198 companies
in the Biotechnology industry
Industry Median: -13.8 vs TVGN: -7.60

Competitive Comparison of Tevogen Bio Holdings's 1-Year Share Buyback Ratio

For the Biotechnology subindustry, Tevogen Bio Holdings's 1-Year Share Buyback Ratio, along with its competitors' market caps and 1-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tevogen Bio Holdings's 1-Year Share Buyback Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tevogen Bio Holdings's 1-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where Tevogen Bio Holdings's 1-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

Tevogen Bio Holdings 1-Year Share Buyback Ratio Calculation

Tevogen Bio Holdings's 1-Year Share Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

1-Year Share Buyback Ratio	=	(Shares Outstanding (EOP) (Dec. 2023 )	-	Shares Outstanding (EOP) (Dec. 2024 ))	/	Shares Outstanding (EOP) (Dec. 2023 )
	=	(165.421	-	177.991)	/	165.421
	=	-7.6%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tevogen Bio Holdings (NAS:TVGN) 1-Year Share Buyback Ratio Explanation

A positive ratio may indicates share buybacks over the period, while a zero or negative ratio suggests no buybacks or potential share issuance.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

Tevogen Bio Holdings 1-Year Share Buyback Ratio Related Terms

Tevogen Bio Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (NAS:TVGN) » Definitions » 1-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

G28:Germany

Address

15 Independence Boulevard, Warren, NJ, USA, 07059

Website

https://www.tevogen.com

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.